190 related articles for article (PubMed ID: 16909008)
21. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
23. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
[TBL] [Abstract][Full Text] [Related]
24. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
[TBL] [Abstract][Full Text] [Related]
25. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Li Y; Liu Y; Wang Z; Jiang Y
Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611
[TBL] [Abstract][Full Text] [Related]
26. Vaccines for Alzheimer's disease: how close are we?
Janus C
CNS Drugs; 2003; 17(7):457-74. PubMed ID: 12751917
[TBL] [Abstract][Full Text] [Related]
27. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K
Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169
[TBL] [Abstract][Full Text] [Related]
28. Vaccine development for Alzheimer's disease.
Dasilva KA; Aubert I; McLaurin J
Curr Pharm Des; 2006; 12(33):4283-93. PubMed ID: 17105428
[TBL] [Abstract][Full Text] [Related]
29. [Alzheimer vaccine].
Tabira T
Nihon Rinsho; 2008 Oct; 66(10):2008-12. PubMed ID: 18939505
[TBL] [Abstract][Full Text] [Related]
30. Current progress in beta-amyloid immunotherapy.
Schenk D; Hagen M; Seubert P
Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
[TBL] [Abstract][Full Text] [Related]
31. [Abeta vaccine therapy for Alzheimer's disease].
Hara H
Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
[TBL] [Abstract][Full Text] [Related]
32. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
Vollmar P; Kullmann JS; Thilo B; Claussen MC; Rothhammer V; Jacobi H; Sellner J; Nessler S; Korn T; Hemmer B
J Immunol; 2010 Nov; 185(10):6338-47. PubMed ID: 20943998
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of Alzheimer disease: A beta vaccine].
Tabira T; Hara H
Rinsho Shinkeigaku; 2004 Nov; 44(11):778-80. PubMed ID: 15651289
[TBL] [Abstract][Full Text] [Related]
35. Active immunization of mice with an Abeta-Hsp70 vaccine.
Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
[TBL] [Abstract][Full Text] [Related]
36. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
37. Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials.
Wilcock DM; Colton CA
J Alzheimers Dis; 2008 Dec; 15(4):555-69. PubMed ID: 19096156
[TBL] [Abstract][Full Text] [Related]
38. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 induces Th2 immune response against amyloid-β in wild-type mouse.
Li Y; Ma Y; Zong LX; Xing XN; Sha S; Cao YP
Neurosci Lett; 2011 Nov; 505(2):128-33. PubMed ID: 22005583
[TBL] [Abstract][Full Text] [Related]
39. Lessons from the AN 1792 Alzheimer vaccine: lest we forget.
Robinson SR; Bishop GM; Lee HG; Münch G
Neurobiol Aging; 2004; 25(5):609-15. PubMed ID: 15172738
[TBL] [Abstract][Full Text] [Related]
40. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
Frenkel D; Dewachter I; Van Leuven F; Solomon B
Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
